Species-specific antibiotic-ribosome interactions: implications for drug development

Area of Science:

• Molecular Biology
• Structural Biology
• Microbiology

Background:

• The protein synthesis machinery in cells is a critical target for antibiotics due to its complexity.
• Numerous crystal structures of ribosomal subunits with antibiotics offer insights into drug interactions and inhibition mechanisms.

Purpose of the Study:

• To investigate species-specific differences in antibiotic binding to ribosomal subunits.
• To understand how variations in ribosomal proteins and rRNA affect drug interactions.

Main Methods:

• Comparative analysis of crystal structures of antibiotic-bound ribosomal subunits from Deinococcus radiodurans (bacterial) and Haloarcula marismortui (archaeal).
• Examination of drug conformation, orientation, and position within the binding sites.

Main Results:

• Generally similar binding modes were observed for macrolides, ketolides, streptogramins, and lincosamides to both bacterial and archaeal ribosomal subunits.
• Small discrepancies in drug binding were identified, primarily attributed to species-specific differences in ribosomal proteins and rRNA at the binding sites.

Conclusions:

• While overall antibiotic binding to ribosomal subunits is conserved, species-specific alterations in ribosomal components influence drug interaction.
• Further understanding of these subtle binding site differences is crucial for the rational design of more potent antibiotic inhibitors.